A Cartier Love Bracelet on display. The brand's owner is keeping U.S. prices stable for now. (Eduardo Parra/Zuma Press) Can the honeymoon phase for Cartier last? The jeweler has so far sat out ...

Swiss jeweler and watchmaker Richemont reported an increase in sales for its fiscal fourth quarter boosted by its core jewelry division, dodging a demand slowdown that is plaguing the luxury ...

PARIS, May 16 (Reuters) - Cartier owner Richemont (CFR.S), opens new tab beat expectations on Friday with a 7% rise in quarterly sales as wealthy shoppers continued to splash out on jewellery ...

Cartier owner Richemont has today reported a slightly better-than-expected 7% rise in quarterly sales as brisk luxury jewellery business in the US partly offset weaker demand for watches in Asia ...

Richemont’s Van Cleef and Cartier have also increased prices on some products. Many luxury brands have pushed through substantial price rises on their products since 2019, with the cost on some ...

Before that, one must navigate from a keypad to a doorbell, from an anonymous door to a double security airlock: the Cartier collection, hidden among several Geneva annexes, is protected like a ...

[BENGALURU] European shares rounded off their fifth week of gains on Friday (May 16), as trade deals out of the US eased tariff worries and strong corporate results provided further boost. The ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...

Bigger than ever, with more movement and new materials – the new Clash de Cartier pieces take the art of contrast to the next level. Since its bold debut in 2019, the Clash de Cartier collection has ...

The BedMed trial of nighttime BP meds, SURMOUNT-5, Troponin URL, gene tests in patients with no disease, and guideline-directed medical therapy for HF are the topics John Mandrola, MD, discusses ...

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA scientists spend less time on repetitive tasks.